Showing results (151-160 of 214) with videos related to

Sort By:
Pageof 22
Oncotarget|July 14, 2016
Comprehensive profiling and quantitation of oncogenic mutations in non small-cell lung carcinoma using single molecule amplification and re-sequencing technologyShirong Zhang, Bing Xia, Hong Jiang, et al.
Cell Death and Differentiation|June 15, 2021
Targeting androgen receptor (AR) with antiandrogen Enzalutamide increases prostate cancer cell invasion yet decreases bladder cancer cell invasion via differentially altering the AR/circRNA-ARC1/miR-125b-2-3p or miR-4736/PPARγ/MMP-9 signalsGang Deng, Ronghao Wang, Yin Sun, et al.
Cancer|March 27, 2009
Stathmin and tubulin expression and survival of ovarian cancer patients receiving platinum treatment with and without paclitaxelDan Su, Stephanie M Smith, Mario Preti, et al.
Neuro-Oncology|June 28, 2023
A novel risk signature for predicting brain metastasis in patients with lung adenocarcinomaYanyan Zhao, Shen Gu, Lingjie Li, et al.
Biomed Research International|June 20, 2019
Comparison of Immune Checkpoint Inhibitors between Older and Younger Patients with Advanced or Metastatic Lung Cancer: A Systematic Review and Meta-AnalysisLeyin Zhang, Leitao Sun, Jieru Yu, et al.
The Journal of Biological Chemistry|July 10, 2009
Endogenous human CaMKII inhibitory protein suppresses tumor growth by inducing cell cycle arrest and apoptosis through down-regulation of the phosphatidylinositide 3-kinase/Akt/HDM2 pathwayShenglin Ma, Yunshan Yang, Chunmei Wang, et al.
Cancers|July 27, 2022
Positive Correlation of Peripheral CD8+ T Lymphocytes with Immune-Related Adverse Events and Combinational Prognostic Value in Advanced Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint InhibitorsKan Wu, Bing Xia, Jing Zhang, et al.
Oncology Letters|November 1, 2017
Notch1 suppresses prostate cancer cell invasion via the metastasis-associated 1-KiSS-1 metastasis-suppressor pathwayGang Deng, Xiaoliang Zheng, Peiwu Jiang, et al.
Diabetes, Obesity & Metabolism|February 7, 2019
The effects of licogliflozin, a dual SGLT1/2 inhibitor, on body weight in obese patients with or without diabetesYan-Ling He, William Haynes, Charles D Meyers, et al.
Frontiers in Oncology|November 28, 2022
Prediction of radiation-induced acute skin toxicity in breast cancer patients using data encapsulation screening and dose-gradient-based multi-region radiomics technique: A multicenter studyHuichun Feng, Hui Wang, Lixia Xu, et al.
Pageof 22